anti-CCR9 immunotoxin 112509 (IgG)-PE

This immunotoxin was achieved by conjugating/fusing the Anti-CCR9 monoclonal antibody to Pseudomonas exotoxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to CCR9 expression cells and enters cells by receptor-mediated endocytosis, then PE cleaved fragments the size of Mr 37000 and 27000, the large fragment and finally into the Golgi and elongation factor 2 (EM) combining it glycosylation inactivation, inhibition of protein synthesis, leading to apoptosis. It was designed for treatment of T cell leukemias or lymphomas, graft-versus-host diseases, and autoimmune diseases.
Supplier Creative Biolabs
Product # AGTO-L046E
Pricing Inquiry
Applications This product is suitable for use in cytotoxicity assay, functional assay and immunotherapy.
Host Mouse
Target CCR9
Species Reactivity Human
Feedback